Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Zenosense Inc. (ZENO) Message Board

Zenosense, Inc. (ZENO) Technologies to Address Key

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 53
Posted On: 01/05/2015 6:52:58 PM
Avatar
Posted By: QualityStocks
Zenosense, Inc. (ZENO) Technologies to Address Key Public Health Concerns

Zenosense is primarily focused on addressing unmet medical needs pertaining to bacterial infections and cancer. Leveraging a collaboration agreement with Sgenia Group subsidiary Zenon Biosystem, Zenosense is developing and plans to market two early detection devices, one for Methicillin-resistant Staphylococcus aureus (MRSA) and one for lung cancer.

MRSA-infected patients are likely to spend three times as long in a hospital, costing the United States’ healthcare system approximately $3.2 billion to $4.2 billion annually. MRSA-infected patients are also five times more likely to die than an uninfected patient, which further emphasizes the drastic need for early detection of hospital acquired infections (HAIs) such as MRSA. Though studies suggest that prevention practices have the potential to slash certain HAIs by up to 70%, there is currently no cost effective early detection device on the market.

Zenon Biosystem recently entered into a collaboration agreement with a university and large university hospital in Madrid, Spain, for a lung cancer detection trial involving breath samples from 400 people. The nine-month trial aims to identify VOCs in exhaled breath using standard lab instruments and techniques alongside two identical pre-commercial lung cancer devices that have been developed by Zenon to determine the relative efficacy of Zenon’s devices.

The Zenosense detection devices utilize a common electronic nose technology platform that analyzes volatile organic compounds (VOCs) found in the exhaled breath of patients and scans for certain biomarkers that indicate the presence of infection or illness before a patient demonstrates any obvious symptoms. The low cost and compact design of the Zenosense device, if successfully developed, would make it possible to be worn by individuals as well as placed in numerous sensitive areas in the healthcare setting.

Once developed, Zenosense’s cost-effective detection devices are expected to cater to a large, high-demand market driven by patient safety, cost and insurance considerations.

For more information, visit www.zenosense.net

Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com


(0)
(0)




Zenosense Inc. (ZENO) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us